V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10410681 | 10065634 | 1.57 | 0 | null | 2019-11-08 | 2019-11-13 | Docetaxel + nintedanib | null | null | IDELALISIB + RITUXIMAB | 101547218 |
| 10413699 | 10065636 | 1.62 | 52 | null | 2019-11-12 | 2019-11-12 | Cytarabine + Venetoclax | 02 | null | CARBOPLATIN + PACLITAXEL + PEMBROLIZUMAB | 100958792 |
| 10417622 | 10065639 | 1.59 | 57 | Neo-adjuvant (N) | null | 2021-02-25 | BOSUTINIB | 02 | N | MERCAPTOPURINE + METHOTREXATE | 101605680 |
| 10421790 | 10065640 | 1.57 | 61 | null | 2019-08-02 | 2019-08-04 | MATRIX (lymphoma) | 02 | null | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100885565 |
| 10431345 | 10065645 | 1.76 | 82.2 | null | 2017-05-23 | 2017-12-13 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101540212 |
| 10435685 | 10065647 | 1.64 | 77.3 | Curative (C) | 2019-06-24 | 2019-07-01 | Vinblastine | 02 | N | ANAGRELIDE | 101680680 |
| 10443120 | 10065652 | 1.7 | 85.4 | null | 2020-12-22 | 2021-10-07 | BEAM | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100256812 |
| 10446586 | 10065653 | null | null | Palliative (P) | 2022-03-08 | 2022-04-20 | PCV | N | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101407014 |
| 10453660 | 10065655 | 1.61 | 64 | Curative (C) | 2017-01-13 | 2017-01-13 | DOCETAXEL + GEMCITABINE | 02 | null | CYTARABINE | 101746091 |
| 10458298 | 10065656 | 1.55 | 97.7 | Palliative (P) | 2020-04-18 | 2020-06-01 | null | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101103577 |
| 10462059 | 10065661 | 1.67 | 104.9 | null | 2019-05-29 | 2019-11-27 | Trial Unspecified | N | null | GEMCITABINE + TREOSULPHAN | 101081425 |
| 10464834 | 10065663 | 1.72 | 87.3 | Palliative (P) | 2022-03-13 | 2022-03-13 | Docetaxel + nintedanib | null | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100372596 |
| 10475499 | 10065670 | 1.84 | 71.4 | Neo-adjuvant (N) | 2019-08-12 | 2019-09-19 | LEAM | 02 | N | FULVESTRANT + RIBOCICLIB | 101779506 |
| 10480687 | 10065672 | 0 | 0 | null | 2021-11-22 | 2021-12-09 | ISATUXIMAB + POMALIDOMIDE | 02 | null | OLAPARIB | 101792844 |
| 10480742 | 10065673 | 1.72 | 78.6 | Disease modification (D) | 2018-06-19 | 2020-01-21 | PCV | 02 | null | MPV | 101861899 |
| 10136138 | 10065675 | null | 87 | Palliative (P) | 2022-01-30 | 2022-02-28 | Cytarabine High Dose | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101813023 |
| 10161782 | 10065676 | 1.65 | 59 | Disease modification (D) | 2015-03-02 | 2019-09-10 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | DOCETAXEL + NINTEDANIB | 101686103 |
| 10219469 | 10065677 | 1.71 | 95 | Neo-adjuvant (N) | 2018-04-29 | 2018-06-03 | FLUOROURACIL + MITOMYCIN | 02 | N | DOCETAXEL + NINTEDANIB | 101437340 |
| 10231904 | 10065678 | 0 | 67.2 | Palliative (P) | 2020-01-16 | 2020-01-30 | ALL UKALL60+ TRIAL | 02 | N | BEXAROTENE | 101636948 |
| 10293097 | 10065683 | 1.58 | 63 | Palliative (P) | 2020-09-19 | 2020-09-19 | Paclitaxel albumin (Abraxane) 21day | 2 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100052121 |
| 10331943 | 10065688 | 1.77 | 79.8 | Palliative (P) | 2020-03-13 | 2020-05-13 | CHLVPP | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100062157 |
| 10410151 | 10065693 | 0 | 73 | null | null | 2019-11-26 | R GCVP | 02 | null | DURVALUMAB | 100800127 |
| 10405118 | 10067146 | 1.78 | 0 | null | null | 2018-07-15 | Rituximab | null | null | RITUXIMAB | 100620615 |
| 10405210 | 10067148 | 1.65 | 83 | Palliative (P) | null | 2018-07-11 | Rituximab | 02 | N | RITUXIMAB | 100046294 |
| 10405355 | 10067149 | 1.7 | 51.8 | Disease modification (D) | 2020-05-14 | 2020-05-30 | IBRUTINIB | 02 | null | IBRUTINIB | 101131236 |
| 10405388 | 10067150 | null | 77.25 | Curative (C) | 2020-01-02 | 2020-01-06 | IBRUTINIB | 02 | N | RITUXIMAB | 100414361 |
| 10405486 | 10067151 | 0 | 81 | null | 2021-02-20 | 2021-10-28 | Rituximab | 02 | null | RITUXIMAB | 100609169 |
| 10405564 | 10067152 | 1.72 | 76.4 | null | null | 2019-11-13 | IBRUTINIB | 99 | null | IBRUTINIB | 101479809 |
| 10408772 | 10067231 | 1.63 | 74 | null | 2020-06-13 | 2020-10-27 | Rituximab | 02 | null | RITUXIMAB | 100905501 |
| 10409021 | 10067246 | 1.73 | 69.2 | null | null | 2022-04-15 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101169880 |
| 10409838 | 10067268 | 1.62 | 83.9 | null | 2017-05-17 | 2017-07-03 | Rituximab (Maintenance) | N | null | IBRUTINIB | 101056854 |
| 10409861 | 10067270 | 1.73 | 61.7 | Palliative (P) | 2020-12-22 | 2021-11-17 | IBRUTINIB | 02 | N | RITUXIMAB | 100342851 |
| 10410140 | 10067279 | 1.57 | 81.2 | null | 2020-04-15 | 2020-05-13 | IBRUTINIB | 02 | null | IBRUTINIB | 100826318 |
| 10410506 | 10067290 | 1.69 | 51.1 | null | 2020-06-02 | 2020-06-02 | IBRUTINIB | null | null | IBRUTINIB | 100412304 |
| 10414996 | 10067438 | 1.73 | 94.7 | null | 2016-06-02 | 2020-06-16 | IBRUTINIB | 02 | null | IBRUTINIB | 100887286 |
| 10415184 | 10067446 | 1.7 | 67.05 | null | 2019-03-30 | 2019-06-21 | Rituximab | null | null | RITUXIMAB | 100141379 |
| 10416540 | 10067487 | 1.77 | 74 | 03 | 2018-03-09 | 2018-03-15 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 101646729 |
| 10421982 | 10067624 | 1.63 | null | null | 2021-04-23 | 2021-06-04 | IBRUTINIB | 02 | null | IBRUTINIB | 100538322 |
| 10422062 | 10067625 | 1.7 | 80 | Palliative (P) | 2016-12-12 | 2020-04-12 | IBRUTINIB | 02 | N | IBRUTINIB | 100481700 |
| 10422236 | 10067626 | 1.65 | 69 | null | 2021-08-18 | 2021-08-23 | IBRUTINIB | 02 | null | IBRUTINIB | 100637028 |
| 10422328 | 10067627 | 1.8 | 57 | null | null | null | IBRUTINIB | 02 | null | IBRUTINIB | 100615607 |
| 10422358 | 10067628 | 1.57 | 70.6 | null | 2016-07-17 | 2016-08-15 | IBRUTINIB | 02 | null | IBRUTINIB | 100157061 |
| 10422399 | 10067629 | 1.83 | 74 | Palliative (P) | 2022-02-24 | 2022-02-24 | IBRUTINIB | 02 | N | IBRUTINIB | 101672702 |
| 10422524 | 10067630 | 1.66 | 59.5 | null | 2013-11-02 | 2013-11-02 | IBRUTINIB | 02 | null | IBRUTINIB | 101842696 |
| 10422565 | 10067631 | 1.56 | 61 | null | null | null | Rituximab | 02 | null | RITUXIMAB | 101073467 |
| 10422642 | 10067632 | 1.72 | 71.8 | null | 2021-07-27 | 2021-08-08 | IBRUTINIB | 02 | null | IBRUTINIB | 101783341 |
| 10422656 | 10067633 | 1.63 | 62 | null | 2019-05-21 | 2019-05-22 | IBRUTINIB | 02 | null | IBRUTINIB | 100422989 |
| 10422709 | 10067634 | 1.63 | 82.5 | null | 2021-08-13 | 2021-08-13 | Rituximab | 02 | null | RITUXIMAB | 101116052 |
| 10422732 | 10067635 | 1.8 | 74 | null | 2016-10-09 | 2022-03-07 | IBRUTINIB | 02 | null | IBRUTINIB | 101736635 |
| 10422785 | 10067637 | 1.85 | 0 | null | 2018-11-20 | 2018-11-23 | IBRUTINIB | 02 | null | IBRUTINIB | 101140861 |